Freedom Investment Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,345
| Closed | -$243K | – | 763 |
|
|
2022
Q3 | $243K | Buy |
4,345
+210
| +5% | +$11.8K | 0.03% | 612 |
|
|
2022
Q2 | $214K | Buy |
+4,135
| New | +$214K | 0.02% | 669 |
|
|
2022
Q1 | – | Sell |
-3,058
| Closed | -$362K | – | 892 |
|
|
2021
Q4 | $362K | Buy |
3,058
+57
| +2% | +$6.75K | 0.03% | 619 |
|
|
2021
Q3 | $403K | Sell |
3,001
-1,852
| -38% | -$249K | 0.03% | 569 |
|
|
2021
Q2 | $786K | Sell |
4,853
-2,308
| -32% | -$374K | 0.06% | 401 |
|
|
2021
Q1 | $575K | Buy |
+7,161
| New | +$575K | 0.04% | 473 |
|